Investors in Hansen Medical Inc. will be allowed to proceed a Delaware Court of Chancery lawsuit alleging the California-based medical robotics firm’s $80 million squeezeout merger with Auris Surgical Robotics Inc. unfairly benefited a group of controlling stockholders who steered the deal.
Vice Chancellor Tamika Montgomery-Reeves on Monday said the proposed class had made a viable case for breach of fiduciary duty against a contingent of major shareholders, which collectively owned a majority stake in Hansen when the company was sold in 2016.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]